BAM
NNVC icon

Blueshift Asset Management’s NanoViricides NNVC Stock Holding History

Blueshift Asset Management’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-20,216
Closed -$95K – 1087
2021
Q1 		$95K Buy
+20,216
New +$91.4K 0.01% 811

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Blueshift Asset Management's NNVC Position: Q2 2021 in Review

Blueshift Asset Management sold out of NanoViricides (NNVC) in Q2 2021, closing a stake of 20,216 shares — an estimated $95K sold.

Blueshift Asset Management first reported a position in NNVC in Q1 2021 and held it in 1 quarter. The position peaked at $95K in Q1 2021. 28 funds tracked by Wall St. Rank hold NNVC as of Q2 2021.

  • Blueshift Asset Management reported no remaining NanoViricides position as of Q2 2021 after selling out during the quarter.
  • Blueshift Asset Management sold 20,216 NanoViricides shares in Q2 2021, an estimated $95K.
  • Blueshift Asset Management first reported a position in NanoViricides in Q1 2021 and held it in 1 quarter.
  • Blueshift Asset Management's NanoViricides position peaked at $95K in Q1 2021.
  • 28 funds tracked by Wall St. Rank held NanoViricides as of Q2 2021.

Based on Blueshift Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.